Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arformoterol Safety Study in COPD
NCT00909779Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jun 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arformoterol in chronic obstructive pulmonary disease (COPD), sponsored by Sumitomo Pharma America. Started Jun 2009; status: completed.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00909779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909779.